Nuvalent, Inc. (NUVL)
96.63
-1.43
(-1.46%)
USD |
NASDAQ |
Mar 27, 16:00
96.63
0.00 (0.00%)
After-Hours: 19:57
Nuvalent Cash from Investing (Quarterly) : -280.94M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Glaukos Corp. | -15.89M |
| Edgewise Therapeutics, Inc. | 49.76M |
| Cogent Biosciences, Inc. | -322.77M |
| Neurocrine Biosciences, Inc. | -52.90M |
| BioMarin Pharmaceutical, Inc. | -42.45M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -73.33M |
| Cash from Financing (Quarterly) | 500.26M |
| Free Cash Flow | -275.21M |
| Free Cash Flow Per Share (Quarterly) | -0.9791 |
| Free Cash Flow to Equity (Quarterly) | -73.33M |
| Free Cash Flow to Firm (Quarterly) | -73.33M |
| Free Cash Flow Yield | -3.92% |